Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2009

The Psoriasis and Psoriatic Arthritis Research, Cure, and Care Act of 2009 (H.R. 930/S. 571) is the first and only bill specific to psoriasis and psoriatic arthritis in Congress. Known as PPARCCA, this bipartisan measure calls upon the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC) to expand their support of research of psoriatic diseases.

Once passed, this legislation will increase the amount of psoriasis research conducted, bringing us closer  to finding a cure for psoriasis.

Specifically, the bill:

1. Expands psoriasis and psoriatic arthritis research conducted by the NIH;
2. Strengthens data collection by establishing a national psoriasis and psoriatic arthritis patient registry through the CDC;
3. Establishes a federal summit on psoriasis and psoriatic arthritis to discuss current issues and efforts and explore opportunities in psoriasis research and care; and
4. Calls for an Institute of Medicine study to evaluate and make recommendations on access to care for people with psoriasis and psoriatic arthritis.

Take action to get PPARCCA passed!

• Write your elected officials urging them to co-sponsor PPARCCA
• Attend a local town hall meeting
• Join the Fair Shake campaign

Learn more about PPARCCA

• PPARCCA FAQs
• PPARCCA bill summary (PDF)
• Senate bill S.571 co-sponsorship status
• House bill H.R. 930 co-sponsorship status